Excellence in Healthcare Delivery Across the Lung Cancer Continuum

GKC for Lung Cancer
  • 0.0 (0)
  • Non-Profit

Season 1: Precision Oncology in NSCLC: HER2 Mutation and Guideline Target Therapies In this seven-part podcast series, leading experts discuss the role of precision oncology in non-small cell lung cancer, with a focus on HER2 mutations and current guideline-based targeted treatment.

Episodes

  1. 4d ago

    S1E1: HER2 Series: Understanding NSCLC Histology and Oncogenesis of HER2 (ERBB2) Mutation in NSCLC

    In this episode, Dr. Andrew Ciupek interviews Dr. Courtney Granville about NSCLC histologic subtypes and HER2 alterations, including mutation, amplification, and overexpression, and how HER2-driven signaling pathways promote tumor growth and progression. Note: this is a companion podcast to the continuing education course in the GO2 for Lung Cancer Global Knowledge Center. Select the link below to go to the full continuing education course: ⁠Understanding NSCLC Histology and Oncogenesis of HER2 (ERBB2) Mutation in NSCLC

  • 1 Episode

About

Season 1: Precision Oncology in NSCLC: HER2 Mutation and Guideline Target Therapies In this seven-part podcast series, leading experts discuss the role of precision oncology in non-small cell lung cancer, with a focus on HER2 mutations and current guideline-based targeted treatment.

Information